Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.
暂无分享,去创建一个
Joe Y. Chang | D. Gomez | P. Balter | Z. Liao | J. Welsh | P. Allen | Qiaoqiao Li | C. Swanick
[1] Joe Y. Chang,et al. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". , 2014, International journal of radiation oncology, biology, physics.
[2] J. Sonke,et al. Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance , 2010 .
[3] P. Smith. No-fly zone. , 2014 .
[4] C. Faivre-Finn,et al. Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): solid evidence or "no-go"? , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] Suresh Senan,et al. Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] Peter Balter,et al. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer , 2012, Radiation oncology.
[7] L. Wilson,et al. Stereotactic Body Radiotherapy for Central Lung Tumors , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[8] Joe Y. Chang,et al. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.
[9] P. Parikh,et al. Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] Shafak Aluwini,et al. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] John Cho,et al. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. , 2012, International journal of radiation oncology, biology, physics.
[12] S. Senan,et al. Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[13] Joe Y. Chang,et al. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. , 2011, International journal of radiation oncology, biology, physics.
[14] Peter A S Johnstone,et al. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver. , 2011, International journal of radiation oncology, biology, physics.
[15] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[16] E. Vokes,et al. Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Peter A S Johnstone,et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] Seong Soo Shin,et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. , 2009, Lung cancer.
[19] Tarek Mekhail,et al. A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[20] M. Schell,et al. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] Joe Y. Chang,et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[22] Lech Papiez,et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Ping Li,et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.
[24] T. Araki,et al. Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.
[25] R. Sutherland,et al. On the nature of the radiobiologically hypoxic fraction in tumors. , 1980, International journal of radiation oncology, biology, physics.